BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28695340)

  • 1. Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response.
    Friedrich C; Shalaby T; Oehler C; Pruschy M; Seifert B; Picard D; Remke M; Warmuth-Metz M; Kortmann RD; Rutkowski S; Grotzer MA; von Bueren AO
    Childs Nerv Syst; 2017 Sep; 33(9):1463-1471. PubMed ID: 28695340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
    Rutkowski S; von Bueren A; von Hoff K; Hartmann W; Shalaby T; Deinlein F; Warmuth-Metz M; Soerensen N; Emser A; Bode U; Mittler U; Urban C; Benesch M; Kortmann RD; Schlegel PG; Kuehl J; Pietsch T; Grotzer M
    Clin Cancer Res; 2007 May; 13(9):2651-7. PubMed ID: 17473196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.
    von Bueren AO; Oehler C; Shalaby T; von Hoff K; Pruschy M; Seifert B; Gerber NU; Warmuth-Metz M; Stearns D; Eberhart CG; Kortmann RD; Rutkowski S; Grotzer MA
    BMC Cancer; 2011 Feb; 11():74. PubMed ID: 21324178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
    Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
    Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
    Sturla LM; Cowan CW; Guenther L; Castellino RC; Kim JY; Pomeroy SL
    Cancer Res; 2005 Jul; 65(13):5683-9. PubMed ID: 15994942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
    Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
    J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
    von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
    Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophin 3/TrkC-regulated proteins in the human medulloblastoma cell line DAOY.
    Gruber-Olipitz M; Ströbel T; Kang SU; John JP; Grotzer MA; Slavc I; Lubec G
    Electrophoresis; 2009 Feb; 30(3):540-9. PubMed ID: 19156760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
    Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
    Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
    Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
    J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
    Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
    Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase expression and TrkC/p75NTR ratios in human medulloblastoma.
    Sinnappah-Kang ND; Mrak RE; Paulsen DB; Marchetti D
    Clin Exp Metastasis; 2006; 23(1):55-63. PubMed ID: 16826429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups.
    Chlapek P; Zitterbart K; Kren L; Filipova L; Sterba J; Veselska R
    PLoS One; 2017; 12(2):e0172552. PubMed ID: 28231263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intellectual Outcome in Molecular Subgroups of Medulloblastoma.
    Moxon-Emre I; Taylor MD; Bouffet E; Hardy K; Campen CJ; Malkin D; Hawkins C; Laperriere N; Ramaswamy V; Bartels U; Scantlebury N; Janzen L; Law N; Walsh KS; Mabbott DJ
    J Clin Oncol; 2016 Dec; 34(34):4161-4170. PubMed ID: 27507873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.
    Grotzer MA; Janss AJ; Fung K; Biegel JA; Sutton LN; Rorke LB; Zhao H; Cnaan A; Phillips PC; Lee VM; Trojanowski JQ
    J Clin Oncol; 2000 Mar; 18(5):1027-35. PubMed ID: 10694553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
    Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
    Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
    Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
    Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma.
    Leal LF; Evangelista AF; de Paula FE; Caravina Almeida G; Carloni AC; Saggioro F; Stavale JN; Malheiros SMF; Mançano B; de Oliveira MA; Luu B; Neder L; Taylor MD; Reis RM
    Neuropathology; 2018 Oct; 38(5):475-483. PubMed ID: 30155928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, chaperoning, and metabolism of proteins are regulated by NT-3/TrkC signaling in the medulloblastoma cell line DAOY.
    Gruber-Olipitz M; Ströbel T; Chen WQ; Grotzer MA; Quehenberger F; Slavc I; Lubec G
    J Proteome Res; 2008 May; 7(5):1932-44. PubMed ID: 18336001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.